文献速递肿瘤 PET/CT

68Ga-FAPI-04 PET/CT对疑似肝结节患者的肝细胞癌成纤维细胞成像:一项先导研究

Fibroblast imaging of hepatic carcinoma with 68Ga-FAPI-04 PET/CT: a pilot study in patients with suspected hepatic nodules.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2020-05-29

一项先导研究纳入25例疑似肝脏恶性病变患者行68Ga-FAPI-04 PET,最终分析17例手术或活检患者,检出28个肝内恶性病灶,平均SUVmax为8.36±4.21,平均TBR为13.15±9.48。68Ga-FAPI-04对肝恶性肿瘤检测灵敏度高,尤其在低分化且FAP表达升高的类型中。

要点

  • 68Ga-FAPI-04 PET对肝恶性病灶检测灵敏度高,28个病灶平均SUVmax为8.36±4.21。
  • 良性患者肝脏摄取可忽略(SUVmax=0.47)。
  • 75%的原发性肝细胞癌病灶(n=6)显示显著FAP表达。

核心结论

  • 68Ga-FAPI-04在检测肝脏恶性肿瘤方面显示出高灵敏度,尤其在低分化且FAP表达相应升高的类型中。

研究设计与样本

  • 先导研究,25例疑似肝脏恶性病变患者行68Ga-FAPI-04 PET,最终17例接受手术或活检者纳入分析。

主要发现

  • 16例患者共检出28个肝内恶性病灶,平均SUVmax为8.36±4.21(范围2.21至15.86),平均TBR为13.15±9.48(范围2.79至38.12)。
  • 1例良性患者肝脏摄取可忽略(SUVmax=0.47)。
  • 75%的原发性肝细胞癌病灶(n=6)显示显著FAP表达,12.5%的病灶(n=1)在基质细胞中显示中度表达,1个病灶显示可忽略表达。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: 68Ga-FAPI-04 is a rapidly evolving PET tracer for whole-body imaging in a variety of cancers. We aimed to evaluate the diagnostic performance of 68Ga-FAPI-04 for detecting and characterizing hepatic nodules in patients with suspected carcinoma. METHODS: Twenty-five patients showing suspicious hepatic lesions for malignancy underwent 68Ga-FAPI-04 PET. The maximum and mean standardised uptake values (SUVmax, SUVmean) were measured for all detected lesions and normal hepatic tissues, respectively. The target-to-background ratio (TBR) was calculated by dividing the lesion SUVmax with the SUVmean of non-tumour liver tissue. Lesion uptake value was correlated with the in vitro hepatic FAP expression determined by immunohistochemistry (IHC). RESULTS: In total, 17 patients who underwent surgery or biopsy were recruited for the final analysis. A total of 28 intrahepatic malignant lesions were detected in 16 patients; the mean SUVmax was 8.36 ± 4.21 (range 2.21 to 15.86), and mean TBR was 13.15 ± 9.48 (range 2.79 to 38.12) in all detected lesions (n = 28). One benign patient showed negligible hepatic uptake (SUVmax = 0.47), whereas 75% of the primary intrahepatic hepatocellular carcinoma (HCC) lesions (n = 6) showed prominent FAP expression, 12.5% of the lesions (n = 1) showed moderate expression in stromal cells, and one showed negligible expression. CONCLUSIONS: 68Ga-FAPI-04 showed high sensitivity in detecting hepatic malignancies, particularly in poorly differentiated forms with concordantly elevated FAP expression.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Shi X, Xing H, Yang X, et al. Fibroblast imaging of hepatic carcinoma with 68Ga-FAPI-04 PET/CT: a pilot study in patients with suspected hepatic nodules. Eur J Nucl Med Mol Imaging. 2020. PMID: 32468254. doi:10.1007/s00259-020-04882-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。